APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polymers Drug Delivery

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Polymers Drug Delivery Market Analysis and Forecast 2026-2032

20 December 2025206 pages

Choose your research edition.

Industry ResearchPolymers Drug Delivery Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Polymers Drug Delivery Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Polymers Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polymers Drug Delivery Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Polymers Drug Delivery Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Polymers Drug Delivery market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Polymers Drug Delivery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Polymers Drug Delivery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Polymers Drug Delivery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Polymers Drug Delivery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Polymers Drug Delivery include Eisai, Sanofi, Johnson & Johnson, Vectura Group Plc, Tolmar, SurModics, Quark Pharmaceuticals Inc, Perrigo and Nektar Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Polymers Drug Delivery, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Polymers Drug Delivery, also provides the revenue of main regions and countries. Of the upcoming market potential for Polymers Drug Delivery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Polymers Drug Delivery revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Polymers Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Polymers Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.

Polymers Drug Delivery Segment by Company

Eisai

Sanofi

Johnson & Johnson

Vectura Group Plc

Tolmar

SurModics

Quark Pharmaceuticals Inc

Perrigo

Nektar Therapeutics

Janssen Biotech

Inovio Pharmaceuticals

Heron

Gilead Sciences

Enzon Pharmaceuticals

EnColl Corporation

Allergan

Alkermes

Polymers Drug Delivery Segment by Type

Micelles

Dendrimer

Hydrogels

Microgels

Other

Polymers Drug Delivery Segment by Application

Medical Research Center

Pharmaceutical Factory

Other

Polymers Drug Delivery Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymers Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polymers Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymers Drug Delivery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Polymers Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Polymers Drug Delivery company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polymers Drug Delivery revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Polymers Drug Delivery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Micelles Major Player Table 3. Dendrimer Major Player Table 4. Hydrogels Major Player Table 5. Microgels Major Player Table 6. Other Major Player Table 7. Global Polymers Drug Delivery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Medical Research Center Major Player Table 9. Pharmaceutical Factory Major Player Table 10. Other Major Player Table 11. Polymers Drug Delivery Industry Trends Table 12. Polymers Drug Delivery Industry Drivers Table 13. Polymers Drug Delivery Industry Opportunities and Challenges Table 14. Polymers Drug Delivery Industry Restraints Table 15. Global Polymers Drug Delivery Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Polymers Drug Delivery Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Polymers Drug Delivery Market Share by Region (2021-2026) Table 18. Global Polymers Drug Delivery Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Polymers Drug Delivery Market Share by Region (2027-2032) Table 20. Global Polymers Drug Delivery Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Polymers Drug Delivery Revenue Market Share by Players (2021-2026) Table 22. Global Polymers Drug Delivery Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Polymers Drug Delivery Key Players Headquarters & Area Served Table 24. Global Polymers Drug Delivery Players, Product Type & Application Table 25. Global Polymers Drug Delivery Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Polymers Drug Delivery by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Polymers Drug Delivery Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Polymers Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Polymers Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Polymers Drug Delivery Revenue Market Share by Type (2021-2026) Table 32. Global Polymers Drug Delivery Revenue Market Share by Type (2027-2032) Table 33. Global Polymers Drug Delivery Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Polymers Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Polymers Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Polymers Drug Delivery Revenue Market Share by Application (2021-2026) Table 37. Global Polymers Drug Delivery Revenue Market Share by Application (2027-2032) Table 38. Eisai Company Information Table 39. Eisai Business Overview Table 40. Eisai Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Eisai Polymers Drug Delivery Product Portfolio Table 42. Eisai Recent Development Table 43. Sanofi Company Information Table 44. Sanofi Business Overview Table 45. Sanofi Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Sanofi Polymers Drug Delivery Product Portfolio Table 47. Sanofi Recent Development Table 48. Johnson & Johnson Company Information Table 49. Johnson & Johnson Business Overview Table 50. Johnson & Johnson Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Johnson & Johnson Polymers Drug Delivery Product Portfolio Table 52. Johnson & Johnson Recent Development Table 53. Vectura Group Plc Company Information Table 54. Vectura Group Plc Business Overview Table 55. Vectura Group Plc Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Vectura Group Plc Polymers Drug Delivery Product Portfolio Table 57. Vectura Group Plc Recent Development Table 58. Tolmar Company Information Table 59. Tolmar Business Overview Table 60. Tolmar Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Tolmar Polymers Drug Delivery Product Portfolio Table 62. Tolmar Recent Development Table 63. SurModics Company Information Table 64. SurModics Business Overview Table 65. SurModics Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. SurModics Polymers Drug Delivery Product Portfolio Table 67. SurModics Recent Development Table 68. Quark Pharmaceuticals Inc Company Information Table 69. Quark Pharmaceuticals Inc Business Overview Table 70. Quark Pharmaceuticals Inc Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Quark Pharmaceuticals Inc Polymers Drug Delivery Product Portfolio Table 72. Quark Pharmaceuticals Inc Recent Development Table 73. Perrigo Company Information Table 74. Perrigo Business Overview Table 75. Perrigo Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Perrigo Polymers Drug Delivery Product Portfolio Table 77. Perrigo Recent Development Table 78. Nektar Therapeutics Company Information Table 79. Nektar Therapeutics Business Overview Table 80. Nektar Therapeutics Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Nektar Therapeutics Polymers Drug Delivery Product Portfolio Table 82. Nektar Therapeutics Recent Development Table 83. Janssen Biotech Company Information Table 84. Janssen Biotech Business Overview Table 85. Janssen Biotech Polymers Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Janssen Biotech Polymers Drug Delivery Product Portfolio Table 87. Janssen Biotech Recent Development Table 88. Inovio Pharmaceuticals Company Information Table 89. Inovio Pharmaceuticals Business Overview Table 90. Inovio Pharmaceuticals Polymers Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Inovio Pharmaceuticals Polymers Drug Delivery Product Portfolio Table 92. Inovio Pharmaceuticals Recent Development Table 93. Heron Company Information Table 94. Heron Business Overview Table 95. Heron Polymers Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Heron Polymers Drug Delivery Product Portfolio Table 97. Heron Recent Development Table 98. Gilead Sciences Company Information Table 99. Gilead Sciences Business Overview Table 100. Gilead Sciences Polymers Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Gilead Sciences Polymers Drug Delivery Product Portfolio Table 102. Gilead Sciences Recent Development Table 103. Enzon Pharmaceuticals Company Information Table 104. Enzon Pharmaceuticals Business Overview Table 105. Enzon Pharmaceuticals Polymers Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Enzon Pharmaceuticals Polymers Drug Delivery Product Portfolio Table 107. Enzon Pharmaceuticals Recent Development Table 108. EnColl Corporation Company Information Table 109. EnColl Corporation Business Overview Table 110. EnColl Corporation Polymers Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. EnColl Corporation Polymers Drug Delivery Product Portfolio Table 112. EnColl Corporation Recent Development Table 113. Allergan Company Information Table 114. Allergan Business Overview Table 115. Allergan Polymers Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Allergan Polymers Drug Delivery Product Portfolio Table 117. Allergan Recent Development Table 118. Alkermes Company Information Table 119. Alkermes Business Overview Table 120. Alkermes Polymers Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Alkermes Polymers Drug Delivery Product Portfolio Table 122. Alkermes Recent Development Table 123. North America Polymers Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Polymers Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Polymers Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 126. North America Polymers Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 127. North America Polymers Drug Delivery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Polymers Drug Delivery Revenue by Country (2021-2026) & (US$ Million) Table 129. North America Polymers Drug Delivery Revenue by Country (US$ Million) & (2027-2032) Table 130. Europe Polymers Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Polymers Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Polymers Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Polymers Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Polymers Drug Delivery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Polymers Drug Delivery Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Polymers Drug Delivery Revenue by Country (US$ Million) & (2027-2032) Table 137. China Polymers Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 138. China Polymers Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 139. China Polymers Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 140. China Polymers Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Polymers Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Polymers Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Polymers Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Polymers Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Polymers Drug Delivery Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Polymers Drug Delivery Revenue by Region (US$ Million) & (2021-2026) Table 147. Asia Polymers Drug Delivery Revenue by Region (US$ Million) & (2027-2032) Table 148. SAMEA Polymers Drug Delivery Revenue by Type (2021-2026) & (US$ Million) Table 149. SAMEA Polymers Drug Delivery Revenue by Type (2027-2032) & (US$ Million) Table 150. SAMEA Polymers Drug Delivery Revenue by Application (2021-2026) & (US$ Million) Table 151. SAMEA Polymers Drug Delivery Revenue by Application (2027-2032) & (US$ Million) Table 152. SAMEA Polymers Drug Delivery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. SAMEA Polymers Drug Delivery Revenue by Country (2021-2026) & (US$ Million) Table 154. SAMEA Polymers Drug Delivery Revenue by Country (US$ Million) & (2027-2032) Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Polymers Drug Delivery Image Figure 2. Global Polymers Drug Delivery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polymers Drug Delivery Market Size Share 2021 VS 2025 VS 2032 Figure 4. Micelles Image Figure 5. Dendrimer Image Figure 6. Hydrogels Image Figure 7. Microgels Image Figure 8. Other Image Figure 9. Global Polymers Drug Delivery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Polymers Drug Delivery Market Size Share 2021 VS 2025 VS 2032 Figure 11. Medical Research Center Image Figure 12. Pharmaceutical Factory Image Figure 13. Other Image Figure 14. Global Polymers Drug Delivery Market Size (US$ Million) & (2021-2032) Figure 15. Global Polymers Drug Delivery Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Polymers Drug Delivery Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Polymers Drug Delivery Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Polymers Drug Delivery Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Polymers Drug Delivery Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Polymers Drug Delivery Revenue Market Share by Type (2021-2032) Figure 22. Global Polymers Drug Delivery Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Polymers Drug Delivery Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Polymers Drug Delivery Revenue Market Share by Application (2021-2032) Figure 25. North America Polymers Drug Delivery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Polymers Drug Delivery Revenue Share by Type (2021-2032) Figure 27. North America Polymers Drug Delivery Revenue Share by Application (2021-2032) Figure 28. North America Polymers Drug Delivery Revenue Share by Country (2021-2032) Figure 29. United States Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Polymers Drug Delivery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Polymers Drug Delivery Revenue Share by Type (2021-2032) Figure 34. Europe Polymers Drug Delivery Revenue Share by Application (2021-2032) Figure 35. Europe Polymers Drug Delivery Revenue Share by Country (2021-2032) Figure 36. Germany Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Polymers Drug Delivery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Polymers Drug Delivery Revenue Share by Type (2021-2032) Figure 46. China Polymers Drug Delivery Revenue Share by Application (2021-2032) Figure 47. Asia Polymers Drug Delivery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Polymers Drug Delivery Revenue Share by Type (2021-2032) Figure 49. Asia Polymers Drug Delivery Revenue Share by Application (2021-2032) Figure 50. Asia Polymers Drug Delivery Revenue Share by Region (2021-2032) Figure 51. Japan Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Polymers Drug Delivery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Polymers Drug Delivery Revenue Share by Type (2021-2032) Figure 59. SAMEA Polymers Drug Delivery Revenue Share by Application (2021-2032) Figure 60. SAMEA Polymers Drug Delivery Revenue Share by Country (2021-2032) Figure 61. Brazil Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Polymers Drug Delivery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Micelles
  • Dendrimer
  • Hydrogels
  • Microgels
  • Other
Applications
  • Medical Research Center
  • Pharmaceutical Factory
  • Other
Companies covered
  • Eisai
  • Sanofi
  • Johnson & Johnson
  • Vectura Group Plc
  • Tolmar
  • SurModics
  • Quark Pharmaceuticals Inc
  • Perrigo
  • Nektar Therapeutics
  • Janssen Biotech
  • Inovio Pharmaceuticals
  • Heron
  • Gilead Sciences
  • Enzon Pharmaceuticals
  • EnColl Corporation
  • Allergan
  • Alkermes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Polymers Drug Delivery Market by Type
  3. 1.2.1 Global Polymers Drug Delivery Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Micelles
  5. 1.2.3 Dendrimer
  6. 1.2.4 Hydrogels
  7. 1.2.5 Microgels
  8. 1.2.6 Other
  9. 1.3 Polymers Drug Delivery Market by Application
  10. 1.3.1 Global Polymers Drug Delivery Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Medical Research Center
  12. 1.3.3 Pharmaceutical Factory
  13. 1.3.4 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Polymers Drug Delivery Market Dynamics
  1. 2.1 Polymers Drug Delivery Industry Trends
  2. 2.2 Polymers Drug Delivery Industry Drivers
  3. 2.3 Polymers Drug Delivery Industry Opportunities and Challenges
  4. 2.4 Polymers Drug Delivery Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Polymers Drug Delivery Market Perspective (2021-2032)
  2. 3.2 Global Polymers Drug Delivery Growth Trends by Region
  3. 3.2.1 Global Polymers Drug Delivery Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Polymers Drug Delivery Market Size by Region (2021-2026)
  5. 3.2.3 Global Polymers Drug Delivery Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Polymers Drug Delivery Revenue by Players
  2. 4.1.1 Global Polymers Drug Delivery Revenue by Players (2021-2026)
  3. 4.1.2 Global Polymers Drug Delivery Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Polymers Drug Delivery Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Polymers Drug Delivery Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Polymers Drug Delivery Key Players Headquarters & Area Served
  7. 4.4 Global Polymers Drug Delivery Players, Product Type & Application
  8. 4.5 Global Polymers Drug Delivery Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Polymers Drug Delivery Market CR5 and HHI
  11. 4.6.3 2025 Polymers Drug Delivery Tier 1, Tier 2, and Tier 3
5 Polymers Drug Delivery Market Size by Type
  1. 5.1 Global Polymers Drug Delivery Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Polymers Drug Delivery Revenue by Type (2021-2032)
  3. 5.3 Global Polymers Drug Delivery Revenue Market Share by Type (2021-2032)
6 Polymers Drug Delivery Market Size by Application
  1. 6.1 Global Polymers Drug Delivery Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Polymers Drug Delivery Revenue by Application (2021-2032)
  3. 6.3 Global Polymers Drug Delivery Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eisai
  2. 7.1.1 Eisai Company Information
  3. 7.1.2 Eisai Business Overview
  4. 7.1.3 Eisai Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eisai Polymers Drug Delivery Product Portfolio
  6. 7.1.5 Eisai Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Polymers Drug Delivery Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Polymers Drug Delivery Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Vectura Group Plc
  20. 7.4.1 Vectura Group Plc Company Information
  21. 7.4.2 Vectura Group Plc Business Overview
  22. 7.4.3 Vectura Group Plc Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Vectura Group Plc Polymers Drug Delivery Product Portfolio
  24. 7.4.5 Vectura Group Plc Recent Developments
  25. 7.5 Tolmar
  26. 7.5.1 Tolmar Company Information
  27. 7.5.2 Tolmar Business Overview
  28. 7.5.3 Tolmar Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Tolmar Polymers Drug Delivery Product Portfolio
  30. 7.5.5 Tolmar Recent Developments
  31. 7.6 SurModics
  32. 7.6.1 SurModics Company Information
  33. 7.6.2 SurModics Business Overview
  34. 7.6.3 SurModics Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  35. 7.6.4 SurModics Polymers Drug Delivery Product Portfolio
  36. 7.6.5 SurModics Recent Developments
  37. 7.7 Quark Pharmaceuticals Inc
  38. 7.7.1 Quark Pharmaceuticals Inc Company Information
  39. 7.7.2 Quark Pharmaceuticals Inc Business Overview
  40. 7.7.3 Quark Pharmaceuticals Inc Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Quark Pharmaceuticals Inc Polymers Drug Delivery Product Portfolio
  42. 7.7.5 Quark Pharmaceuticals Inc Recent Developments
  43. 7.8 Perrigo
  44. 7.8.1 Perrigo Company Information
  45. 7.8.2 Perrigo Business Overview
  46. 7.8.3 Perrigo Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Perrigo Polymers Drug Delivery Product Portfolio
  48. 7.8.5 Perrigo Recent Developments
  49. 7.9 Nektar Therapeutics
  50. 7.9.1 Nektar Therapeutics Company Information
  51. 7.9.2 Nektar Therapeutics Business Overview
  52. 7.9.3 Nektar Therapeutics Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Nektar Therapeutics Polymers Drug Delivery Product Portfolio
  54. 7.9.5 Nektar Therapeutics Recent Developments
  55. 7.10 Janssen Biotech
  56. 7.10.1 Janssen Biotech Company Information
  57. 7.10.2 Janssen Biotech Business Overview
  58. 7.10.3 Janssen Biotech Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Janssen Biotech Polymers Drug Delivery Product Portfolio
  60. 7.10.5 Janssen Biotech Recent Developments
  61. 7.11 Inovio Pharmaceuticals
  62. 7.11.1 Inovio Pharmaceuticals Company Information
  63. 7.11.2 Inovio Pharmaceuticals Business Overview
  64. 7.11.3 Inovio Pharmaceuticals Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Inovio Pharmaceuticals Polymers Drug Delivery Product Portfolio
  66. 7.11.5 Inovio Pharmaceuticals Recent Developments
  67. 7.12 Heron
  68. 7.12.1 Heron Company Information
  69. 7.12.2 Heron Business Overview
  70. 7.12.3 Heron Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Heron Polymers Drug Delivery Product Portfolio
  72. 7.12.5 Heron Recent Developments
  73. 7.13 Gilead Sciences
  74. 7.13.1 Gilead Sciences Company Information
  75. 7.13.2 Gilead Sciences Business Overview
  76. 7.13.3 Gilead Sciences Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Gilead Sciences Polymers Drug Delivery Product Portfolio
  78. 7.13.5 Gilead Sciences Recent Developments
  79. 7.14 Enzon Pharmaceuticals
  80. 7.14.1 Enzon Pharmaceuticals Company Information
  81. 7.14.2 Enzon Pharmaceuticals Business Overview
  82. 7.14.3 Enzon Pharmaceuticals Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Enzon Pharmaceuticals Polymers Drug Delivery Product Portfolio
  84. 7.14.5 Enzon Pharmaceuticals Recent Developments
  85. 7.15 EnColl Corporation
  86. 7.15.1 EnColl Corporation Company Information
  87. 7.15.2 EnColl Corporation Business Overview
  88. 7.15.3 EnColl Corporation Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  89. 7.15.4 EnColl Corporation Polymers Drug Delivery Product Portfolio
  90. 7.15.5 EnColl Corporation Recent Developments
  91. 7.16 Allergan
  92. 7.16.1 Allergan Company Information
  93. 7.16.2 Allergan Business Overview
  94. 7.16.3 Allergan Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Allergan Polymers Drug Delivery Product Portfolio
  96. 7.16.5 Allergan Recent Developments
  97. 7.17 Alkermes
  98. 7.17.1 Alkermes Company Information
  99. 7.17.2 Alkermes Business Overview
  100. 7.17.3 Alkermes Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Alkermes Polymers Drug Delivery Product Portfolio
  102. 7.17.5 Alkermes Recent Developments
8 North America
  1. 8.1 North America Polymers Drug Delivery Revenue (2021-2032)
  2. 8.2 North America Polymers Drug Delivery Revenue by Type (2021-2032)
  3. 8.2.1 North America Polymers Drug Delivery Revenue by Type (2021-2026)
  4. 8.2.2 North America Polymers Drug Delivery Revenue by Type (2027-2032)
  5. 8.3 North America Polymers Drug Delivery Revenue Share by Type (2021-2032)
  6. 8.4 North America Polymers Drug Delivery Revenue by Application (2021-2032)
  7. 8.4.1 North America Polymers Drug Delivery Revenue by Application (2021-2026)
  8. 8.4.2 North America Polymers Drug Delivery Revenue by Application (2027-2032)
  9. 8.5 North America Polymers Drug Delivery Revenue Share by Application (2021-2032)
  10. 8.6 North America Polymers Drug Delivery Revenue by Country
  11. 8.6.1 North America Polymers Drug Delivery Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Polymers Drug Delivery Revenue by Country (2021-2026)
  13. 8.6.3 North America Polymers Drug Delivery Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Polymers Drug Delivery Revenue (2021-2032)
  2. 9.2 Europe Polymers Drug Delivery Revenue by Type (2021-2032)
  3. 9.2.1 Europe Polymers Drug Delivery Revenue by Type (2021-2026)
  4. 9.2.2 Europe Polymers Drug Delivery Revenue by Type (2027-2032)
  5. 9.3 Europe Polymers Drug Delivery Revenue Share by Type (2021-2032)
  6. 9.4 Europe Polymers Drug Delivery Revenue by Application (2021-2032)
  7. 9.4.1 Europe Polymers Drug Delivery Revenue by Application (2021-2026)
  8. 9.4.2 Europe Polymers Drug Delivery Revenue by Application (2027-2032)
  9. 9.5 Europe Polymers Drug Delivery Revenue Share by Application (2021-2032)
  10. 9.6 Europe Polymers Drug Delivery Revenue by Country
  11. 9.6.1 Europe Polymers Drug Delivery Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Polymers Drug Delivery Revenue by Country (2021-2026)
  13. 9.6.3 Europe Polymers Drug Delivery Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Polymers Drug Delivery Revenue (2021-2032)
  2. 10.2 China Polymers Drug Delivery Revenue by Type (2021-2032)
  3. 10.2.1 China Polymers Drug Delivery Revenue by Type (2021-2026)
  4. 10.2.2 China Polymers Drug Delivery Revenue by Type (2027-2032)
  5. 10.3 China Polymers Drug Delivery Revenue Share by Type (2021-2032)
  6. 10.4 China Polymers Drug Delivery Revenue by Application (2021-2032)
  7. 10.4.1 China Polymers Drug Delivery Revenue by Application (2021-2026)
  8. 10.4.2 China Polymers Drug Delivery Revenue by Application (2027-2032)
  9. 10.5 China Polymers Drug Delivery Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Polymers Drug Delivery Revenue (2021-2032)
  2. 11.2 Asia Polymers Drug Delivery Revenue by Type (2021-2032)
  3. 11.2.1 Asia Polymers Drug Delivery Revenue by Type (2021-2026)
  4. 11.2.2 Asia Polymers Drug Delivery Revenue by Type (2027-2032)
  5. 11.3 Asia Polymers Drug Delivery Revenue Share by Type (2021-2032)
  6. 11.4 Asia Polymers Drug Delivery Revenue by Application (2021-2032)
  7. 11.4.1 Asia Polymers Drug Delivery Revenue by Application (2021-2026)
  8. 11.4.2 Asia Polymers Drug Delivery Revenue by Application (2027-2032)
  9. 11.5 Asia Polymers Drug Delivery Revenue Share by Application (2021-2032)
  10. 11.6 Asia Polymers Drug Delivery Revenue by Country
  11. 11.6.1 Asia Polymers Drug Delivery Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Polymers Drug Delivery Revenue by Country (2021-2026)
  13. 11.6.3 Asia Polymers Drug Delivery Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Polymers Drug Delivery Revenue (2021-2032)
  2. 12.2 SAMEA Polymers Drug Delivery Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Polymers Drug Delivery Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Polymers Drug Delivery Revenue by Type (2027-2032)
  5. 12.3 SAMEA Polymers Drug Delivery Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Polymers Drug Delivery Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Polymers Drug Delivery Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Polymers Drug Delivery Revenue by Application (2027-2032)
  9. 12.5 SAMEA Polymers Drug Delivery Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Polymers Drug Delivery Revenue by Country
  11. 12.6.1 SAMEA Polymers Drug Delivery Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Polymers Drug Delivery Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Polymers Drug Delivery Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst